NCT06308822

Clinical Trial Information

Trial Number: NCT06308822 (ClinicalTrials.gov)

Disease Type:

Hematopoietic Neoplasm/Lymphoma - Miscellaneous
Hematopoietic Neoplasm/Myeloma - Myeloma
Miscellaneous Neoplasm - Solid Tumor

Trial Title:

MATCH Treatment Subprotocol K1: Phase 2 Study of JNJ-42756493 (Erdafitinib) in Patients With Tumors With FGFR Amplifications

Study ID:

EAY131-K1

Images are available?:

No

Is this a NCI-MATCH Trial?:

No

Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security

U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov

NIH…Turning Discovery Into Health^®